My Personalised Breast Screening
The PERFORMS scheme is now accredited by the European Accreditation Council for Continuing Medical Education(EACCME)
What to expect?
MyPeBS is a EU funded clinical research project that compares the current standard breast screening with a personalised strategy that is based on the personal risk of developing breast cancer for each individual woman.
The MyPeBS study involves 25 partners from seven different countries, including 1,000 leading medical professionals, scientists and prestigious institutions engaged in breast cancer research and prevention. The €12.5m study is funded by the EU Horizon 2020 Research and Innovation Programme.
The iPERFORMS team will provide quality assessment to confirm that trial radiologists are reporting breast screening cases at a suitable level of screening accuracy and ensure that they all are of an equivalent international standard.
This is the largest study in the world on the subject, and individualization is a major trend.
DR SUZETTE DELALOGE, ASSOCIATE PROFESSOR OF MEDICAL ONCOLOGY, HEAD OF BREAST CANCER DEPARTMENT, GUSTAVE ROUSSY INSTITUTE, PARIS, FRANCE
COVID-19 Training SetFIND OUT MORE
PERFORMS EQAFIND OUT MORE
PROSPECTSFIND OUT MORE
Digital Pathology TrialFIND OUT MORE
Breast Pathology EQAFIND OUT MORE
PERFECTS EQAFIND OUT MORE
PRISMFIND OUT MORE
Grand ChallengeFIND OUT MORE
Breast AssessmentFIND OUT MORE
IMPROVEFIND OUT MORE
PERFORMS InternationalFIND OUT MORE